351 related articles for article (PubMed ID: 18250412)
1. pConsensus peptide induces tolerogenic CD8+ T cells in lupus-prone (NZB x NZW)F1 mice by differentially regulating Foxp3 and PD1 molecules.
Singh RP; La Cava A; Hahn BH
J Immunol; 2008 Feb; 180(4):2069-80. PubMed ID: 18250412
[TBL] [Abstract][Full Text] [Related]
2. Blockade of programmed death-1 in young (New Zealand black x New Zealand white)F1 mice promotes the activity of suppressive CD8+ T cells that protect from lupus-like disease.
Wong M; La Cava A; Singh RP; Hahn BH
J Immunol; 2010 Dec; 185(11):6563-71. PubMed ID: 21041733
[TBL] [Abstract][Full Text] [Related]
3. Cellular and Molecular Phenotypes of pConsensus Peptide (pCons) Induced CD8
Singh RP; Hahn BH; Bischoff DS
Front Immunol; 2021; 12():718359. PubMed ID: 34867947
[TBL] [Abstract][Full Text] [Related]
4. Effects of Peptide-Induced Immune Tolerance on Murine Lupus.
Singh RP; Hahn BH; Bischoff DS
Front Immunol; 2021; 12():662901. PubMed ID: 34093553
[TBL] [Abstract][Full Text] [Related]
5. Interferon-inducible gene 202b controls CD8(+) T cell-mediated suppression in anti-DNA Ig peptide-treated (NZB × NZW) F1 lupus mice.
Dinesh R; Hahn BH; La Cava A; Singh RP
Genes Immun; 2011 Jul; 12(5):360-9. PubMed ID: 21326316
[TBL] [Abstract][Full Text] [Related]
6. CD8+ T cell-mediated suppression of autoimmunity in a murine lupus model of peptide-induced immune tolerance depends on Foxp3 expression.
Singh RP; La Cava A; Wong M; Ebling F; Hahn BH
J Immunol; 2007 Jun; 178(12):7649-57. PubMed ID: 17548601
[TBL] [Abstract][Full Text] [Related]
7. Tolerogenic treatment of lupus mice with consensus peptide induces Foxp3-expressing, apoptosis-resistant, TGFbeta-secreting CD8+ T cell suppressors.
Hahn BH; Singh RP; La Cava A; Ebling FM
J Immunol; 2005 Dec; 175(11):7728-37. PubMed ID: 16301683
[TBL] [Abstract][Full Text] [Related]
8. Distinct gene signature revealed in white blood cells, CD4(+) and CD8(+) T cells in (NZBx NZW) F1 lupus mice after tolerization with anti-DNA Ig peptide.
Singh RP; Dinesh R; Elashoff D; de Vos S; Rooney RJ; Patel D; La Cava A; Hahn BH
Genes Immun; 2010 Jun; 11(4):294-309. PubMed ID: 20200542
[TBL] [Abstract][Full Text] [Related]
9. Differences between CD8+ T cells in lupus-prone (NZB x NZW) F1 mice and healthy (BALB/c x NZW) F1 mice may influence autoimmunity in the lupus model.
Karpouzas GA; La Cava A; Ebling FM; Singh RR; Hahn BH
Eur J Immunol; 2004 Sep; 34(9):2489-99. PubMed ID: 15307181
[TBL] [Abstract][Full Text] [Related]
10. Protection against renal disease in (NZB x NZW)F(1) lupus-prone mice after somatic B cell gene vaccination with anti-DNA immunoglobulin consensus peptide.
Ferrera F; Hahn BH; Rizzi M; Anderson M; Fitzgerald J; Millo E; Indiveri F; Shi FD; Filaci G; La Cava A
Arthritis Rheum; 2007 Jun; 56(6):1945-53. PubMed ID: 17530718
[TBL] [Abstract][Full Text] [Related]
11. The suppression of murine lupus by a tolerogenic peptide involves foxp3-expressing CD8 cells that are required for the optimal induction and function of foxp3-expressing CD4 cells.
Sharabi A; Mozes E
J Immunol; 2008 Sep; 181(5):3243-51. PubMed ID: 18713995
[TBL] [Abstract][Full Text] [Related]
12. CD4+ T lymphocytes with constitutive CD40 ligand in preautoimmune (NZB x NZW)F1 lupus-prone mice: phenotype and possible role in autoreactivity.
Lettesjö H; Burd GP; Mageed RA
J Immunol; 2000 Oct; 165(7):4095-104. PubMed ID: 11034421
[TBL] [Abstract][Full Text] [Related]
13. A peptide derived from an autoantibody can stimulate T cells in the (NZB x NZW)F1 mouse model of systemic lupus erythematosus.
Ebling FM; Tsao BP; Singh RR; Sercarz E; Hahn BH
Arthritis Rheum; 1993 Mar; 36(3):355-64. PubMed ID: 7680861
[TBL] [Abstract][Full Text] [Related]
14. CD4+ T cells from (New Zealand Black x New Zealand White)F1 lupus mice and normal mice immunized against apoptotic nucleosomes recognize similar Th cell epitopes in the C terminus of histone H3.
Fournel S; Neichel S; Dali H; Farci S; Maillère B; Briand JP; Muller S
J Immunol; 2003 Jul; 171(2):636-44. PubMed ID: 12847228
[TBL] [Abstract][Full Text] [Related]
15. Treatment with a consensus peptide based on amino acid sequences in autoantibodies prevents T cell activation by autoantigens and delays disease onset in murine lupus.
Hahn BH; Singh RR; Wong WK; Tsao BP; Bulpitt K; Ebling FM
Arthritis Rheum; 2001 Feb; 44(2):432-41. PubMed ID: 11229475
[TBL] [Abstract][Full Text] [Related]
16. Ig-reactive CD4+CD25+ T cells from tolerized (New Zealand Black x New Zealand White)F1 mice suppress in vitro production of antibodies to DNA.
La Cava A; Ebling FM; Hahn BH
J Immunol; 2004 Sep; 173(5):3542-8. PubMed ID: 15322219
[TBL] [Abstract][Full Text] [Related]
17. An Ig mu-heavy chain transgene inhibits systemic lupus erythematosus immunopathology in autoimmune (NZB x NZW)F1 mice.
Wellmann U; Letz M; Schneider A; Amann K; Winkler TH
Int Immunol; 2001 Dec; 13(12):1461-9. PubMed ID: 11717187
[TBL] [Abstract][Full Text] [Related]
18. Genetic control of the spontaneous activation of CD4+ Th cells in systemic lupus erythematosus-prone (NZB x NZW) F1 mice.
Fujii T; Iida Y; Yomogida M; Ikeda K; Haga T; Jikumaru Y; Ninami M; Nishimura N; Kodera Y; Inada Y; Shirai T; Hirose S; Nishimura H
Genes Immun; 2006 Dec; 7(8):647-54. PubMed ID: 17024131
[TBL] [Abstract][Full Text] [Related]
19. Modulation of p38 MAPK activity in regulatory T cells after tolerance with anti-DNA Ig peptide in (NZB x NZW)F1 lupus mice.
Lourenço EV; Procaccini C; Ferrera F; Iikuni N; Singh RP; Filaci G; Matarese G; Shi FD; Brahn E; Hahn BH; La Cava A
J Immunol; 2009 Jun; 182(12):7415-21. PubMed ID: 19494264
[TBL] [Abstract][Full Text] [Related]
20. Murine models of systemic lupus erythematosus: B and T cell responses to spliceosomal ribonucleoproteins in MRL/Fas(lpr) and (NZB x NZW)F(1) lupus mice.
Monneaux F; Dumortier H; Steiner G; Briand JP; Muller S
Int Immunol; 2001 Sep; 13(9):1155-63. PubMed ID: 11526096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
